Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Applying CAS, EUGOGO, VISA: A Micro Case
Why Staging TED Correctly Matters Even When CAS Is Low
Kimberly Cockerham, MD
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Designing Efficient Clinic Workflows for TED Therapy Access
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Recognizing Geographic Atrophy Progression in AMD
Brian P. McDonough, MD, FAAFP
Jaclyn Kovach, MD
Advancing Uveitis Care: Emerging Challenges and Research Opportunities
Steven Yeh, MD, FASRS
Vitreous Sensing Vitrectomy
Maria Berrocal
Jordan D. Deaner, MD
Observation vs. Vitrectomy for Floaters
Kyle Davis Kovacs, MD
Matthew Starr, MD
Nita Valikodath, MD, MS
New Methotrexate Protocol in RD Repair in High-Risk PVR Cases
Maria H. Berrocal, MD
Maggie Runner, MD
Choosing the Right Therapy for RVO Patients
Michael Javaheri, MD, MSc, FASRS
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Managing RVO: Goals of Early Intervention
Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Akshay Thomas, M.D., M.S., FASRS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.